|Articles|April 1, 2004
Individualized treatment essential with ocular hypertension
Philadelphia-The Ocular Hypertension Treatment Study (OHTS), the results of which were first reported 1 year ago, has changed the way some ophthalmologists treat patients with ocular hypertension, according to George Spaeth, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5









































.png)


